Press Release

Diabetes Drugs Market to Gain US$ 78,261.7 mn by the End of 2026

Diabetes Drugs Market by Top Key Players are Johnson & Johnson, Bayer Pharmaceuticals, Novo Nordisk and more

The Global Diabetes Drugs Market is expected to reach US$ 78,261.7 mn by 2026 owing to rising prevalence of diabetes the world over. Key insights into this growing market have been shared by Fortune Business Insights in its report, titled “Diabetes Drugs Market Size, Share and Global Trend By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors), Diabetes Type (Type 1, Type 2), Route of Administration (Oral, Subcutaneous, Intravenous), Distribution Channel (Online pharmacies, Hospital Pharmacies, Retail Pharmacies) & Geography Forecast till 2026”.

Browse Complete Report Details @ https://www.fortunebusinessinsights.com/industry-reports/diabetes-drugs-market-100570

“Some of the Main Key Players Covered in the Report”

  • Johnson & Johnson
  • Bayer Pharmaceuticals
  • Novo Nordisk
  • Sanofi
  • Merck
  • Eli Lilly and Company
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim
  • Novartis

“Undiagnosed Sections May Hinder Market Growth”

The Centre for Disease Control and Prevention revealed that around 7.2 mn people in the US remained undiagnosed in 2017. The global diabetes drugs market may see restrained growth as a result, since a large number of people remain untapped.

However, as lifestyles get more sedentary and diagnostic methods get more advanced, the market is sure to gain momentum between 2018 and 2026 and register a CAGR of 6.1%.

Order Full Report @ https://www.fortunebusinessinsights.com/checkout-page/100570

“Rising Number of Type 2 Diabetes Cases to Fuel the Market”

Diabetes has various forms and the most prevalent ones include Type 1 (body fails to make any insulin), Type 2 (body does not make enough insulin), gestational (develops in pregnant women), and monogenic (rare genetic form of diabetes). Type 2 diabetes is the most common form of diabetes as it develops during middle age. The global diabetes drugs market is expected to grow considerably as Type 2 diabetes becomes even more widespread. Increasing sedentary lifestyle, rising stress levels, lack of exercise leading to obesity, and unhealthy food habits are the factors cited for the growth of the market.

“North America Expected to Dominate the Market”

North America is expected to hold a large chunk of the market share in the forecast period. This evaluation is based on the region’s revenue generation of USD 23,965.5 million in 2018. Moreover, rising prevalence of diabetes in the US is encouraging companies to develop novel and affordable drugs for the patients.

Growing awareness among the people regarding diabetes and anti-diabetic drugs in North America will aid growth of the global diabetes drugs market. North America is expected to be followed by Europe in terms of market share and revenue generation during the forecast period.

When the body does not make enough insulin or fails to make any insulin at all, a person becomes diabetic. The disease has no cure and can cause major health problems with age. Diabetes drugs are the medication that an affected person has to consume to regulate her glucose levels.

“Market Competition Set to Intensify”

Key players are increasing their investments in research and development activities and launching new products to maintain their competitive edge. For example, in July 2019, the National Institute for Health and Care Excellence cleared Forxiga for treating Type 1 diabetes in England and Wales. The drug has been developed jointly by Bristol-Myers Squibb and AstraZeneca.  The global diabetes drug market is expected to grow as a result.

Fortune Business Insights identifies some key players in the market which include Johnson and Johnson Services, Eli Lilly and Company, AstraZeneca, Novartis AG, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Sanofi, and a few others.

“More Trending Topics from Fortune Business Insights”

Breast Implants Market Showing Impressive Growth by 2026 | Trends, Share, Top Key Vendors, Industry Analysis and Forecast Research

Commercial Seed Market Top Key Players, Business Opportunities, Global Trend, Share by Forecast to 2025

Next-Generation Sequencing Market Bussiness Opportunity, Industry Growth, Trends, Share, Size, Key Players Analysis by 2026

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close